Entourage Health Launches New Premium Color Cannabis Products
January 27, 2022 08:00 ET
|
Entourage Health Corp.
TORONTO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Posts New Year 2022 Shareholder Newsletter
January 06, 2022 08:15 ET
|
Entourage Health Corp.
TORONTO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing
December 24, 2021 12:18 ET
|
Entourage Health Corp.
TORONTO, Dec. 24, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Enhances Cultivation Platform with Tissue Culture IP and Introduces New Genetics for Premium Adult-Use and Medical Product Lineup in 2022
December 15, 2021 08:10 ET
|
Entourage Health Corp.
TORONTO, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health Reports Q3 Financial Results with $14.9 Million Record Revenue Representing 94% YOY Increase and Fourth Consecutive Quarter of Growth
November 16, 2021 07:00 ET
|
Entourage Health Corp.
Adult-Use net revenue for the quarter increased by 102% compared to last yearSales, general and administrative costs decreased by 16% compared to last yearStrategic acquisition of craft cultivator...
Entourage Health Closes Acquisition of Craft Cultivator CannTx Life Sciences Inc.
November 01, 2021 07:05 ET
|
Entourage Health Corp.
Closing of deal merges craft brand Royal City Cannabis Co. into Entourage’s product portfolio Company enhances board with two new appointments from CannTx Life SciencesEntourage also completes...
Entourage Health Announces Preliminary Q3 Record Revenue of $14.7 Million and Confirms Financial Results Call to be Held on November 16, 2021 at 10 a.m. ET
October 19, 2021 08:36 ET
|
Entourage Health Corp.
Fourth consecutive quarter of growth attributed to expanding market share and record salesCompany also completes amendments to its $39 million senior secured credit facility TORONTO, Oct. 19, 2021 ...
Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth
August 10, 2021 07:05 ET
|
Entourage Health Corp.
Continued record sales of higher-margin products in all channels drives 29% gross marginFulfilled record purchase orders from every province, focusing on top-performing products resulting in a 159%...
Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET
July 20, 2021 08:05 ET
|
Entourage Health Corp.
TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:WDDMF) (FSE:4WE) (“Entourage” or the “Company”), is pleased to announce preliminary...
WeedMD Added to Horizons Marijuana Life Sciences Index ETF
March 30, 2021 08:00 ET
|
WeedMD Rx Inc.
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is...